Dr. Ben Wolozin
Co-Founder and the Chief Scientific Officer
Life Science
Aquinnah Pharmaceuticals
United States of America
Biography
Dr. Wolozin holds an MD and Ph.D. degree and has extensive research experience in this field. He is a distinguished scientist who identified one of the first molecular markers for the tangle pathology that accumulates in neurons in Alzheimer’s disease. He was also the first to identify the link between the use of statins (a cholesterol lowering drug) and reduced rates of Alzheimer’s disease. More recently, he discovered the role of persistent stress granules in ALS and Alzheimer’s disease. He has won multiple awards for his research, including the prestigious Zenith Fellows Award and the A. E. Bennett award from the Society for Neuroscience.
Research Interest
He is a distinguished scientist who identified one of the first molecular markers for the tangle pathology that accumulates in neurons in Alzheimer’s disease.
